Organogenesis Apligraf Approvable For Diabetic Foot Ulcers With Conditions
This article was originally published in The Gray Sheet
Executive Summary
Physicians using Organogenesis' Apligraf for treatment of diabetic foot ulcers should be cautioned that clinical studies of the living skin substitute compared the product to standard care only, FDA's General and Plastic Surgery Device Advisory Panel recommended May 8 in considering the company's application to expand labeling.